RecruitingNCT04905537

Study on Early Genetic Screening and Precise Strategy of Neonatal Critical Illness


Sponsor

Children's Hospital of Fudan University

Enrollment

4,000 participants

Start Date

Jan 1, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

The researchers hope to establish an overall program of early genetic screening for neonatal critical illness in China, and to develop precise intervention strategies to assist clinical diagnosis and treatment of hereditary critical illness.


Eligibility

Max Age: 100 Days

Inclusion Criteria4

  • Postnatal age less than 100 days;
  • Perinatal death after 20 weeks of gestation (more than 500 g)
  • Can be retained biological samples for genetic screening;
  • Biological parent or guardian's informed consent.

Exclusion Criteria8

  • Reluctance of parents to use genetic sequencing data for subsequent research;
  • Parents under 18 years of age or incapacitated for decision-making;
  • subjects older than 100 days;
  • Perinatal death less than 20 weeks of gestation or weight less than 500 g;
  • Inherited metabolic diseases with chromosomal abnormalities;
  • Multiple pregnancies;
  • Lack of access to biological samples from which DNA can be extracted;
  • Failure to sign informed consent.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNo intervention

It's only observational study. No interventions.


Locations(1)

Children's Hospital of Fudan University

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04905537


Related Trials